Volume Spike Investor

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is getting its wings clipped this morning.  The company received a complete response letter from FDA for FUSILEV in advanced metastatic colorectal cancer.  The response noted that it did not demonstrate that FUSILEV is non-inferior to leucovorin and recommended that it meet with them to discuss options for continuing to [...]

Novavax Inc. (NASDAQ: NVAX) is getting spanked this morning. The swine flu stock and flu stock is trading lower after Oppenheimer & Co. downgraded the biotechnology company after shares went above and beyond the firm;s $6.00 price target.  The rating is now “Perform” rather than “Outperform” as before.   At the 9:30 Opening Bell NVAX is [...]

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) shares are up more than 5 percent to $6.20 in early premarket trading of fewer than 2,000 shares. The FDA has given a fast-track designation for the company’s investigation of its apaziquone candidate for the treatment of non-muscle invasive bladder cancer.  — Mike Tarsala

Specrtum Pharmaceuticals (Nasdaq: SPPI) are 20%  as of 7:45 a.m. Eastern on about 3,000 shares traded.  The FDA asked for data from the company’s already completed Phase III study to support the company’s proposed labeling of its product Zevalin as a first-line consolidation therapy for treating non-Hodgkins lymphoma.
No additional clinical studies have been requested. The additional [...]

Spectrum Pharmaceuticals Inc. (Nasdaq: SPPI) Inc. shares are down roughly 8 percent on nearly 60,000 shares traded as of 8:15 a.m. Eastern. The company announced early this morning that it will raise $21 million from institutional investors at $7.15 a share. The stock had been trading near $7.65 a share. — Mike Tarsala